FDA issues public health advisory on NEJM report

Share this article:
The FDA will issue a public health advisory based on a June 8 New England Journal of Medicine report of an increased risk of birth defects when women take ACE inhibitors during the first trimester of pregnancy. The FDA says women should stop using them as soon as possible after pregnancy is detected.
Share this article:

Email Newsletters

More in News

Astellas, DOJ settle for $7.3M

Astellas, DOJ settle for $7.3M

Astellas has settled a False Claims case with the Department of Justice over the 2010-2013 marketing of an antifungal medication. Astellas denies the allegations.

Boehringer drug lands US, EU orphan tag

Boehringer drug lands US, EU orphan tag

The experimental Breakthrough Therapy treatment is for acute myeloid leukemia.

Omnio app moves to smartphones

Omnio app moves to smartphones

Physicians Interactive is introducing the third wave of its Omnio app, making the tablet-only tool available for iPhones and Android phones.